Aarti Pharmalabs Bull Case Target Achieved
Authored By Prime Research | Published at: Aug 11, 2026 02:57 PM IST
Stocks in News
Open Free Demat Account
Aarti Pharmalabs bull case target achieved
In our pick of the week report dated Dec 14, 2025, we had recommended to buy Aarti Pharmalabs in the band of Rs 733-751 band and add on dips to Rs 645-653 for base case target of Rs 814 and bull case target of Rs 868 over the next 2-3 quarters.
Today, the stock hit a high of Rs 908, thereby achieved bull case target of Rs 868, and yielding a return of 15.6%.
Disclaimer
At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Join Us
Add as preferred source on Google
